跳至主要内容
临床试验/NCT00556153
NCT00556153撤回不适用

[F-18]Fluoro-DOPA PET Imaging of Brain Tumors in Children

Children's Hospital Medical Center, Cincinnati0 个研究点开始时间: 2013年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
撤回
主要终点
Increased uptake of [F-18]FDOPA in pediatric brain tumors compared to contralateral normal brain tissue as measured by standardized uptake value and tumor/non-tumor uptake ratios

研究概览

简要总结

The first phase of the study will investigate if there is increased uptake of [F-18]FDOPA in pediatric brain tumors when compared to normal brain tissue.

详细描述

The first phase of the study will investigate if there is increased uptake of [F-18]FDOPA in pediatric brain tumors when compared to normal brain tissue. Tne subjects between ages 5 and 17 years will be studies, to determine if there is increased uptake of [F-18]FDOPA in pediatric brain tumors when compared to normal brain tissue. Drug safety will also be monitored.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
5 Years 至 15 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Documented brain tumor at diagnosis or relapse, including high grade glioma, low grade glioma, medulloblastoma including PNET, optic pathway glioma, brainstem glioma, ependymoma.

排除标准

  • Pregnancy
  • Requirement for sedation
  • Lack of informed consent

研究组 & 干预措施

Phase I

Children, ages 5-15 years with brain tumors

干预措施: [F-18]Fluoro-DOPA PET, a diagnostic radiopharmaceutical (Drug)

结局指标

主要结局

Increased uptake of [F-18]FDOPA in pediatric brain tumors compared to contralateral normal brain tissue as measured by standardized uptake value and tumor/non-tumor uptake ratios

时间窗: 15-30 minutes after IV administration

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验